🔗 Permalink

Inventor profile of:

Daniel J. Drucker

City:

Toronto

Country:

Canada

Published Applications:

Last publication date:

2015-10-15

Top Assignees for applications by Daniel J. Drucker

The entities that hold a legal rights for patent applications filed by inventor Drucker Daniel J.:

1149336 Ontario, Inc. 10 Toronto, Canada
NPS PHARMACEUTICALS, INC. 5 Bedminster, NJ United States
1149336 Ontario, Inc. 3 Toronto, Ontario, Canada
New England Medical Center Hospitals, Inc. 3 Boston, MA United States
Trustees of Tufts College 3 Boston, MA United States
1149336 Ontario Inc. 2 , Canada
1149336 Ontario, Inc. 1 Toronton, ON Canada
MOUNT SINAI HOSPITAL 1 Toronto, ON Canada
1149336 Ontario, Inc. 1 Toronto, ON, Canada
1149336 Ontario Inc. 1 Ontario, Canada
Mount Sinai Hospital 1 Toronto, Ontario, Canada

Recent patent applications by Drucker Daniel J.

Daniel J. Drucker from Toronto, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-10-15

US20150290295A1

Human necessities

METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE

#2 | 2014-07-31

US20140213518A1

Chemistry; metallurgy

METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE

#3 | 2014-06-26

US20140178472A1

Human necessities

Methods of regulating glucose metabolism, and reagents related thereto

#4 | 2013-08-08

US20130203673A1

Human necessities

Glucagon-like peptide-2 analogs

#5 | 2013-02-28

US20130053316A1

Human necessities

Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist

#6 | 2012-12-27

US20120328527A1

Human necessities

Methods of enhancing functioning of the large intestine

#7 | 2012-06-28

US20120165252A1

Human necessities

Method of regulating glucose metabolism, and reagents related thereto

#8 | 2011-11-10

US20110275568A1

Human necessities

Methods of enhancing functioning of the large intestine

#9 | 2011-09-15

US20110223108A1

Human necessities

GLUCAGON-LIKE PEPTIDE-2 AND ITS THERAPEUTIC USE

#10 | 2011-07-14

US20110172149A1

Human necessities

Method of regulating glucose metabolism, and reagents related thereto

#11 | 2011-01-13

US20110009320A1

Human necessities

Glucagon-like peptide-2 analogs

#12 | 2011-01-04

US10829201

Enhancement of GLP-2 activity of suppressing appetite

#13 | 2010-08-24

US10293941

Glucagon-like peptide-2 analogs

#14 | 2010-05-13

US20100119453A1

Human necessities

Methods of enhancing functioning of the large intestine

#15 | 2007-06-07

US20070129304A1

Human necessities

Methods of enhancing functioning of the large intestine

#16 | 2007-02-13

US10419150

Methods of enhancing functioning of the large intestine

#17 | 2006-05-23

US10042746

Glucagon-like peptide-2 and its therapeutic use

#18 | 2006-05-18

US20060105954A1

Human necessities

Glucagon-like peptide-2 and its therapeutic use

InventorID:

115975 ⎘